Abstract | INTRODUCTION: Application of emollients is a widespread traditional newborn care practice in many low and middle-income countries (LMICs) and may have the potential to decrease infection and consequent mortality in preterm neonates. METHODS: We systematically reviewed literature published up to December 2012 to identify studies describing the effectiveness of emollient therapy. We used a standardized abstraction and grading format to estimate the effect of emollient therapy by applying the standard Child Health Epidemiology Reference Group (CHERG) rules. RESULTS: We included seven studies and one unpublished trial in this review. Topical emollient therapy significantly reduced neonatal mortality by 27% (RR: 0.73, 95% CI: 0.56, 0.94) and hospital acquired infection by 50% (RR: 0.50, 95% CI: 0.36, 0.71). There were significant increases in weight (g) (MD: 98.04, 95% CI: 42.64, 153.45) and weight gain (g/kg/day) (MD: 1.57, 95% CI: 0.79, 2.36), whereas the impacts were non-significant for length and head circumference. CONCLUSION:
Emollient therapy is associated with improved weight gain, reduced risk of infection and associated newborn mortality in preterm neonates and is a potentially promising intervention for use in low resource settings. Large scale effectiveness trials are required to further assess the impact of this intervention.
|
Authors | Rehana A Salam, Jai K Das, Gary L Darmstadt, Zulfiqar A Bhutta |
Journal | BMC public health
(BMC Public Health)
Vol. 13 Suppl 3
Pg. S31
( 2013)
ISSN: 1471-2458 [Electronic] England |
PMID | 24564550
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Cross Infection
(prevention & control)
- Developing Countries
- Emollients
(therapeutic use)
- Evidence-Based Medicine
- Female
- Humans
- Infant
- Infant Care
(methods)
- Infant Welfare
(statistics & numerical data)
- Infant, Newborn
- Infant, Premature
- Infant, Premature, Diseases
(prevention & control)
- Weight Gain
|